Plumbago zeylanica
Species
KNApSAcK Entry
| Organism name | Plumbago zeylanica |
|---|---|
| Genus | Plumbago |
| Family | Plumbaginaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Plumbago zeylanica |
|---|---|
| Linked NCBI taxonomy ID | 76149 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Plumbaginaceae |
|---|---|
| ID | 4437 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | eudicotyledons |
|---|---|
| ID | 71240 |
Natural Activity
List (30)
| Species | Activity |
|---|---|
| Plumbago Zeylanica L. | Abortifacient |
| Plumbago Zeylanica L. | Alexeteric |
| Plumbago Zeylanica L. | Alterative |
| Plumbago Zeylanica L. | Antibacterial |
| Plumbago Zeylanica L. | Antifertility |
| Plumbago Zeylanica L. | Antiimplantation |
| Plumbago Zeylanica L. | Antipyretic |
| Plumbago Zeylanica L. | Antiseptic |
| Plumbago Zeylanica L. | Aphrodisiac |
| Plumbago Zeylanica L. | Astringent |
| Plumbago Zeylanica L. | Bitter |
| Plumbago Zeylanica L. | Carminative |
| Plumbago Zeylanica L. | Choleretic |
| Plumbago Zeylanica L. | Diaphoretic |
| Plumbago Zeylanica L. | Digestive |
| Plumbago Zeylanica L. | Diuretic |
| Plumbago Zeylanica L. | Expectorant |
| Plumbago Zeylanica L. | Fungicide |
| Plumbago Zeylanica L. | Hypokinetic |
| Plumbago Zeylanica L. | Laxative |
| Plumbago Zeylanica L. | Orexigenic |
| Plumbago Zeylanica L. | Parasiticide |
| Plumbago Zeylanica L. | Rubefacient |
| Plumbago Zeylanica L. | Scabicide |
| Plumbago Zeylanica L. | Sialagogue |
| Plumbago Zeylanica L. | Stimulant |
| Plumbago Zeylanica L. | Tonic |
| Plumbago Zeylanica L. | Vermifuge |
| Plumbago Zeylanica L. | Vesicant |
| Plumbago Zeylanica L. | Vulnerary |
Metabolite list (16)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00005374
|
Quercetin
|
CHEMBL82242
CHEMBL479232 CHEMBL1437696 |
C012526
|
14 / 2 / 2 | 2 / 1 | No. 2 | No. 15 |
|
|
C00003672
|
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
|
||
|
C00032817
|
Chitranone
|
CHEMBL470658
|
No. 312 |
|
||||
|
C00032634
|
3,3'-Biplumbagin
|
C079946
|
No. 312 |
|
||||
|
C00037864
|
Suberosin
|
CHEMBL1928409
|
1 / 0 / 0 | No. 466 | No. 25 |
|
||
|
C00036600
|
5-Methoxyseselin
|
CHEMBL479894
|
No. 750 | No. 25 |
|
|||
|
C00032520
|
Xanthoxyletin
|
CHEMBL501358
|
14 / 5 / 7 | No. 750 | No. 25 |
|
||
|
C00002505
|
Xanthyletin
|
CHEMBL303846
|
C020814
|
29 / 43 / 58 | No. 750 | No. 25 |
|
|
|
C00000300
|
Seselin
/ Amyrolin / Seseline |
CHEMBL71358
|
2 / 0 / 0 | No. 750 | No. 25 |
|
||
|
C00002852
|
Plumbagin
/ Plumbagine |
CHEMBL295316
|
C014758
|
28 / 30 / 59 | 14 / 3 | No. 1047 | No. 80 |
|
|
C00002818
|
Droserone
|
CHEMBL1915212
|
No. 1119 | No. 80 |
|
|||
|
C00001396
|
L-Tryptophan
|
CHEMBL54976
CHEMBL292303 CHEMBL484901 |
49 / 41 / 39 | No. 1432 | No. 4 |
|
||
|
C00025312
|
Isoshinanolone
/ cis-Isoshinanolone / (+)-cis-Isoshinanolone |
CHEMBL1094242
CHEMBL2023569 |
No. 1520 |
|
||||
|
C00036561
|
3'-O-beta-Glucopyranosyl plumbagic acid methyl ester
|
No. 3825 |
|
|||||
|
C00036560
|
3'-O-beta-Glucopyranosyl plumbagic acid
|
No. 3825 |
|
|||||
|
C00001361
|
Glycine
|
CHEMBL773
|
95 / 37 / 32 | No. 3932 |
|
Human Protein / Gene in interactions
186 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001396 C00002505 C00002852 C00005374 C00032520 | 0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001361 C00001396 C00002852 C00003672 | 0 / 1 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00001361 C00001396 C00002505 C00032520 | 1 / 2 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001361 C00001396 C00003672 | 1 / 0 |
| P00915 | Carbonic anhydrase 1 | Lyase | C00001396 C00002505 C00032520 | 0 / 0 |
| P56817 | Beta-secretase 1 | A1A | C00000300 C00002505 C00037864 | 0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001361 C00001396 C00003672 | 0 / 0 |
| O43570 | Carbonic anhydrase 12 | Lyase | C00001396 C00002505 C00032520 | 1 / 2 |
| Q16790 | Carbonic anhydrase 9 | Lyase | C00001396 C00002505 C00032520 | 0 / 1 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002505 C00002852 C00005374 | 0 / 0 |
| P43166 | Carbonic anhydrase 7 | Lyase | C00001396 C00002505 C00032520 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001396 C00002505 C00002852 | 4 / 3 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001396 C00002852 C00005374 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001361 C00001396 C00003672 | 1 / 1 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001361 C00001396 C00003672 | 0 / 1 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001396 C00005374 | 0 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00002505 C00003672 | 0 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001396 C00002852 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00001361 C00002505 | 1 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00001361 C00003672 | 1 / 1 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002505 C00032520 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002505 C00032520 | 0 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001396 C00003672 | 2 / 0 |
| P29466 | Caspase-1 | C14 | C00001361 C00002852 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002505 C00002852 | 3 / 3 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00002852 C00005374 | 0 / 0 |
| P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00000300 C00002505 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001396 C00032520 | 0 / 0 |
| Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002505 C00032520 | 0 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00002505 C00002852 | 4 / 1 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001361 C00002852 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002505 C00032520 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001396 C00002852 | 1 / 2 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002505 C00032520 | 0 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00001396 C00003672 | 3 / 2 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002852 C00003672 | 1 / 1 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002505 C00002852 | 7 / 37 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001396 C00002852 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001396 C00005374 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00001396 C00002852 | 2 / 5 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002505 C00032520 | 2 / 2 |
| Q05BR4 | SLC16A10 protein | Unclassified protein | C00001361 C00001396 | 0 / 0 |
| P54132 | Bloom syndrome protein | Enzyme | C00001396 C00002852 | 1 / 2 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002505 C00002852 | 2 / 2 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001361 | 1 / 0 |
| P02768 | Serum albumin | Secreted protein | C00001396 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00003672 | 1 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001361 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001361 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001361 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| P07237 | Protein disulfide-isomerase | Enzyme | C00005374 | 0 / 0 |
| Q99558 | Mitogen-activated protein kinase kinase kinase 14 | Unique STE serine/threonine protein kinase | C00002852 | 0 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001361 | 0 / 0 |
| Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00001396 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001361 | 1 / 8 |
| P11387 | DNA topoisomerase 1 | Isomerase | C00002852 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00002852 | 2 / 3 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001361 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001361 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001361 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001361 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001361 | 0 / 0 |
| P23280 | Carbonic anhydrase 6 | Lyase | C00001396 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001361 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001361 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001361 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001361 | 1 / 0 |
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00001396 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001361 | 1 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00001361 | 0 / 0 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00001361 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001361 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001396 | 0 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001361 | 1 / 1 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 1 |
| P42858 | Huntingtin | Unclassified protein | C00001396 | 1 / 1 |
| O75496 | Geminin | Unclassified protein | C00001396 | 0 / 0 |
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002505 | 0 / 0 |
| P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002505 | 4 / 2 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001361 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001361 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001361 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001361 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
| P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001361 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00001361 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001361 | 0 / 0 |
| P15121 | Aldose reductase | Enzyme | C00005374 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001361 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001361 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00005374 | 1 / 1 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 | 0 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001361 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00001361 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001361 | 1 / 0 |
| P37840 | Alpha-synuclein | Unclassified protein | C00002505 | 4 / 2 |
| P03956 | Interstitial collagenase | M10A | C00001361 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001361 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00002505 | 7 / 3 |
| Q04206 | Transcription factor p65 | Transcription Factor | C00002852 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00005374 | 1 / 1 |
| P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00001396 | 0 / 0 |
| P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00001396 | 3 / 1 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005374 | 0 / 0 |
| Q9Y263 | Phospholipase A-2-activating protein | Unclassified protein | C00001396 | 0 / 0 |
| P23415 | Glycine receptor subunit alpha-1 | GLR alpha | C00001361 | 1 / 1 |
| P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002852 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002852 | 0 / 0 |
| P00734 | Prothrombin | S1A | C00003672 | 4 / 2 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00001361 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001361 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001361 | 0 / 0 |
| P14679 | Tyrosinase | Oxidoreductase | C00003672 | 4 / 2 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001361 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001361 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001361 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001361 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00001361 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001361 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001361 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001361 | 0 / 0 |
| P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00001361 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001361 | 1 / 0 |
| P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001361 | 2 / 1 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001396 | 11 / 10 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00001361 | 2 / 2 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001361 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00001361 | 0 / 0 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001396 | 1 / 1 |
| Q16773 | Kynurenine--oxoglutarate transaminase 1 | Enzyme | C00001396 | 0 / 0 |
| O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002505 | 1 / 1 |
| Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00001396 | 5 / 2 |
| P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001396 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001361 | 0 / 0 |
| Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001396 | 0 / 0 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001361 | 1 / 0 |
| P46059 | Solute carrier family 15 member 1 | Dipeptide | C00001361 | 0 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001361 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001361 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001361 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00001361 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001361 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001361 | 0 / 0 |
| P48775 | Tryptophan 2,3-dioxygenase | Enzyme | C00001396 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001361 | 0 / 0 |
| P55210 | Caspase-7 | C14 | C00002852 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001361 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001361 | 0 / 0 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001361 | 0 / 0 |
| P08246 | Neutrophil elastase | S1A | C00001361 | 2 / 1 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00005374 | 0 / 0 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001361 | 2 / 2 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001361 | 0 / 3 |
| Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001396 | 0 / 0 |
| Q7Z2H8 | Proton-coupled amino acid transporter 1 | Unclassified protein | C00001361 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001361 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001361 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001361 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001361 | 1 / 1 |
| P07451 | Carbonic anhydrase 3 | Lyase | C00001396 | 0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00001361 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001361 | 0 / 0 |
| P04049 | RAF proto-oncogene serine/threonine-protein kinase | Raf | C00002852 | 2 / 0 |
| P08254 | Stromelysin-1 | M10A | C00001396 | 1 / 0 |
| P22748 | Carbonic anhydrase 4 | Lyase | C00001396 | 1 / 1 |
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
| Q99700 | Ataxin-2 | Unclassified protein | C00002505 | 1 / 1 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00001396 | 0 / 0 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00002852 | 0 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001396 | 0 / 0 |
| Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00005374 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002505 | 1 / 0 |
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 | 0 / 0 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001396 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001396 | 1 / 4 |
| Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | C00002852 | 1 / 1 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00005374 | 0 / 0 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00032520 | 1 / 1 |
16 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00005374
|
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00005374
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002852
|
| 2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00002852
|
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00002852
|
| 3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00002852
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002852
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002852
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00002852
|
| 1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00002852
|
| 7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00002852
|
| 54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00002852
|
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002852
|
| 54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002852
|
| 54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002852
|
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002852
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (127)
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #218030 | Apparent mineralocorticoid excess; ame |
P80365
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #114480 | Breast cancer |
P38398
|
| #604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
| #300615 | Brunner syndrome |
P21397
|
| #615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
| #162800 | Cyclic neutropenia |
P08246
|
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #133239 | Esophageal cancer |
P04637
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
| #139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #143860 | Hyperchlorhidrosis, isolated |
O43570
|
| #149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #146300 | Hypophosphatasia, adult |
P05186
|
| #241510 | Hypophosphatasia, childhood |
P05186
|
| #241500 | Hypophosphatasia, infantile |
P05186
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #611554 | Leopard syndrome 2 |
P04049
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
| #611553 | Noonan syndrome 5; ns5 |
P04049
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
P38398 |
| #614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P37840
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
| #613679 | Prothrombin deficiency, congenital |
P00734
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601367 | Stroke, ischemic |
P00734
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #278300 | Xanthinuria, type i |
P47989
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (110)
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
| H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
| H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00223 | Inherited thrombophilia |
P00734
(related)
|
| H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) P38398 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) P38398 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00213 | Hypophosphatasia |
P05186
(related)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
| H00769 | Hyperekplexia |
P23415
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
| H00523 | Noonan syndrome and related disorders |
Q02750
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00208 | Hyperbilirubinemia |
Q92887
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|